|
|
|
|
| LEADER |
02970pamja2200349 4500 |
| 001 |
0000044533_0037 |
| 005 |
20170202090000.0 |
| 008 |
070809s2008 nyua b 001 0 eng |
| 020 |
|
|
|a 9780824758097 (hb : alk. paper)
|
| 020 |
|
|
|a 0824758099 (hb : alk. paper)
|
| 090 |
0 |
0 |
|a RS201.S57
|b P74 2008
|
| 245 |
0 |
0 |
|a Preformulation in solid dosage form development
|c edited by Moji C. Adeyeye, Harry G. Brittain..
|
| 260 |
|
|
|a New York :
|b Informa Healthcare USA,
|c c2008.
|
| 300 |
|
|
|a viii, 596 p. :
|b ill. ;
|c 24 cm.
|
| 440 |
|
0 |
|a Drugs and the pharmaceutical sciences ;;
|v 178
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Accelerating the course of preliminary-preformulation through prediction of molecular physical properties and integrated analytical data management / Robert S. DeWitte, Michel Hachey, and Harry G. Brittain -- Prediction of crystallographic characteristics / Steve Spanton -- Salt selection for pharmaceutical compounds / Sherif I. Badawy, Miriam K. Franchini, and Munir A. Hussain -- Intelligent preformulation design and predictions using artificial neural networks / Nkere K. Ebube -- Developing a profile of the active pharmaceutical ingredient / Harry G. Brittain -- Particle morphology and characterization in preformulation / Alan Rawle -- Preparation and identification of polymorphs and solvatomorphs / Harry G. Brittain -- X-ray diffraction methods for the characterization of solid pharmaceutical materials / Jean Blachere and Harry G. Brittain -- Spectroscopic methods for the characterization of drug substances / Harry G. Brittain -- Thermal analysis and calorimetric methods for the characterization of new crystal forms / Dennette Murphy Shelley Rabel -- Solubility methods for the characterization of new crystal forms / Harry G. Brittain -- Overview of the solid dosage form preformulation program / Harry G. Brittain -- Drug-excipient interactions appropriate to solid dosage forms / Moji Christianah Adeyeye -- Methods for the determination of the physical and chemical stability of a new solid dosage form / Harry G. Brittain -- Dissolution testing / Chuck Collins and George Wong -- Structure, content, and format of the preformulation report / Ram N. Gidwani -- Significance of drug substance physicochemical properties in regulatory quality by design / Sau Lawrence Lee, Andre S. Raw, and Lawrence Yu.
|
| 650 |
|
0 |
|a Solid dosage forms
|
| 650 |
|
2 |
|a Chemistry, Pharmaceutical
|
| 650 |
0 |
2 |
|a Pharmaceutical Preparations
|x chemical synthesis
|
| 650 |
|
0 |
|a Pharmaceutical chemistry
|
| 650 |
|
0 |
|a Drug development
|
| 650 |
0 |
2 |
|a Dosage Forms
|
| 700 |
1 |
|
|a Adeyeye,
|h Moji C.
|
| 700 |
1 |
|
|a Brittain,
|h H. G.
|
| 856 |
0 |
0 |
|u http://www.loc.gov/catdir/toc/ecip0725/2007033181.html
|
| 856 |
0 |
0 |
|u http://www.loc.gov/catdir/enhancements/fy0740/2007033181-d.html
|
| 999 |
|
|
|a 0000064714
|
| 999 |
|
|
|a 0000064715
|
| 999 |
|
|
|a 0000064716
|
| 999 |
|
|
|a 0000064717
|
| 999 |
|
|
|a 0000064718
|
